Aarti Drugs Ltd
NSE:AARTIDRUGS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Dividends
Dividend Yield
Aarti Drugs Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Aarti Drugs Ltd
AARTIDRUGS have
increased
by 700%.
Payout Ratio
Aarti Drugs Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for AARTIDRUGS is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
AARTIDRUGS Price
Aarti Drugs Ltd
| Average Annual Return | -8.64% |
| Standard Deviation of Annual Returns | 13.63% |
| Max Drawdown | -61% |
| Market Capitalization | 34.8B INR |
| Shares Outstanding | 91 270 000 |
| Percentage of Shares Shorted |
N/A
|
AARTIDRUGS Return Decomposition
Main factors of price return
Stock Splits
AARTIDRUGS's latest stock split occurred on Sep 30, 2020
The company executed a 4-for-1 stock split, meaning that for every share held, investors received 4 new shares.
Before the split, AARTIDRUGS traded at 2938.4 per share. Afterward, the share price was about 764.94.
The adjusted shares began trading on Sep 30, 2020. This was AARTIDRUGS's 3rd stock split, following the previous one in Mar 24, 2015.
